Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers

This is a Phase 1, open-label, multiple-dose study to evaluate the safety, tolerability, and PK of MGB after weekly subQ MGB administration in up to 36 healthy volunteers at 1 site in Australia.

Participants needed: 36
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Ashvattha Therapeutics, Inc.Updated: Feb 4, 2026
Eligibility criteria

Healthy man or woman age 18 to 65 years, inclusive, at the Screening Visit [+16]

Evidence of clinically significant hematologic, renal, endocrine, pulmonary, car... [+10]

Status: Recruiting

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP-801 is intended as a biomarker for PET imaging of activated microglia and macrophages in regions of neuroinflammation.

Participants needed: 65
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Ashvattha Therapeutics, Inc.Updated: May 2, 2025Locations: 3
Eligibility criteria

Has the ability to understand and sign the written ICF and local medical privacy... [+34]

Body weight >120 kg [+23]